Life Sciences 1994-01-01

Pituitary adenylate cyclase activating polypeptide (PACAP) potently enhances tyrosine hydroxylase (TH) expression in adrenal chromaffin cells.

R A Rius, A Guidotti, E Costa

Index: Life Sci. 54(22) , 1735-43, (1994)

Full Text: HTML

Abstract

In primary cultured bovine adrenal chromaffin cells (BACC), pituitary adenylate cyclase activating polypeptide 1-38 (PACAP) produced a dose related increase in tyrosine hydroxylase (TH) Vmax when measured 48 hours after the beginning of the treatment; a significant increase was observed with 0.5 nM and the maximal induction of close to 2.5-fold was found with 0.1 microM PACAP. The potency of PACAP was nearly 3 orders of magnitude greater than forskolin and VIP in inducing TH activity. These effects were preceded by an increase in TH mRNA levels, that started 2 hours after treatment and peaked 12 hours later. The presence of the phosphodiesterase inhibitor HL 725 further increased the stimulation of TH activity by PACAP, indicating that this activation was mediated via a cascade of events initiated by cAMP. Nicotine (1 microM) failed to increase TH activity significantly, however, when added in association with PACAP, a statistically significant increase of TH was elicited with peptide concentrations 5 times lower (0.1 nM) than the threshold dose of the peptide. The stimulation of nicotinic receptors facilitates the TH induction elicited by PACAP.


Related Compounds

Related Articles:

Atrial natriuretic peptide reduces cyclic AMP by activating cyclic GMP-stimulated phosphodiesterase in vascular endothelial cells.

1994-09-01

[J. Cardiovasc. Pharmacol. 24(3) , 351-7, (1994)]

Role of cGMP-inhibited phosphodiesterase and sarcoplasmic calcium in mediating the increase in basal heart rate with nitric oxide donors.

2000-10-01

[J. Mol. Cell. Cardiol. 32(10) , 1831-40, (2000)]

Effects of colforsin, trequinsin and isoprenaline on norepinephrine-induced contractions and cyclic nucleotide levels of isolated vascular tissue.

1988-02-01

[Arzneimittelforschung 38(2) , 240-3, (1988)]

Dissociation between phosphodiesterase inhibition and antiproliferative effects of phosphodiesterase inhibitors on the Dami cell line.

1997-04-25

[Biochem. Pharmacol. 53(8) , 1141-7, (1997)]

Mutational mapping of kinetic and pharmacological properties of a human cardiac cAMP phosphodiesterase.

1994-12-02

[J. Biol. Chem. 269(48) , 30676-81, (1994)]

More Articles...